Neal. L. Benowitz MD - Medical Marijuana

Name:	Neal. L. Benowitz, MD
Title:	Chief of the Division of Clinical Pharmacology and Experimental Therapeutics at the University of California, San Franscisco
Position:	None Found to the question "Should marijuana be a medical option?"
Reasoning:	No position found as of 2005
Credibility Ranking:	Key Experts Physicians [Physicians are the "key experts" in the medical marijuana debate because the issue is thought by many to be ultimately based on the medical value and risks of marijuana, and Physicians, with their training and clinical work, should (at least in theory) have the best knowledge of marijuana's medical value and risks.] [Note: Key Experts definition varies by site]
Involvement and Affiliations:	Professor, Departments of Medicine, Psychiatry and Pharmacy, University of California , San Francisco (UCSF) 1987-Present Chief, Division of Clinical Pharmacology and Experimental Therapeutics, UCSF, 1983-present Associate Medical Director, San Francisco Bay Area Regional Poison Center, 1970-present Professor of Medicine, Psychiatry, and Pharmacy, UCSF Fellow in Clinical Pharmacology, Department of Medicine, University of California, San Francisco, 1971-1993 Director, Drug Detoxification Unit, San Francisco General Hospital, 1975-76
Education:	Intern and Resident, Internal Medicine, Bronx Municipal Hospital Center, 1969-1971 MD, University of Rochester School of Medicine, 1969 Rensselaer Polytechnic Institute
Contact Info:	Phone: 415-206-8324 Fax: 415-206-4956 E-Mail: nbeno@itsa.ucsf.edu Website: University profile
Select Publications:	Cowritten with P. Jacob, III, "Trans-31-hydroxycotinine: Disposition Kinetics, Effects, and Plasma Levels During Cigarette Smoking," British Journal of Clinical Pharmacology, 2001 Cowritten with C.A. Haller, "Adverse Cardiovascular and Central Nervous System Events Associated with Dietary Supplements Containing Ephedra Alkaloids," New England Journal of Medicine, 2000 Cowritten with P. Jacob, III, W. Yu, and L. Yu, "Simultaneous Determination of Mecamylamine, Nicotine, and Cotinine in Plasma By Gas Chromatography-mass Spectrometry," Journal Of Pharmaceutical And Biomedical Analysis, 2000 Cowritten with K. Fattinger, R.T. Jones and D. Verotta, "Nasal Mucosal Versus Gastrointestinal Absorption of Nasally Administered Cocaine," Eur. J. Clinical Pharmacology & Therapeutics, 2000 Cowritten with S. Zevin, P. Jacob III, and P. Geppetti, "Clinical Pharmacology of Oral Cotinine, Drug and Alcohol Dependence, 2000 Cowritten with S. Zevin, and P. Jacob, III, "Nicotine-mecamylamine Interactions," Clinical Pharmacology & Therapeutics, 2000 Cowritten with D. Dempsey, and P. Jacob, III, "Nicotine Metabolism and Elimination Kinetics in Newborns," Clinical Pharmacology & Therapeutics, 2000 Cowritten with P. Jacob, III, "Effects of Cigarette Smoking and Carbon Monoxide on Nicotine and Cotinine Metabolism." Clinical Pharmacology & Therapeutics, 2000
Other:	None found

Last Updated On: 5/8/2008 1:18:00 PM